Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-22
DOI
10.3389/fmed.2022.791653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical imaging and nuclear medicine: a Lancet Oncology Commission
- (2021) Hedvig Hricak et al. LANCET ONCOLOGY
- Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
- (2021) Susan E. Dorman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis
- (2021) Han Na Lee et al. PLoS One
- A Comparative Study of Chest Computed Tomography Findings: 1030 Cases of Drug-Sensitive Tuberculosis versus 516 Cases of Drug-Resistant Tuberculosis
- (2021) Nianlan Cheng et al. Infection and Drug Resistance
- 4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India – a randomised clinical trial
- (2020) Banurekha Velayutham et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Clustered micronodules as predominant manifestation on CT: A sign of active but indolently evolving pulmonary tuberculosis
- (2020) Jung Hee Hong et al. PLoS One
- Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection
- (2020) Ismaheel O. Lawal et al. Clinical and Translational Imaging
- Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters
- (2019) Ismaheel O. Lawal et al. PLoS One
- FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS
- (2019) Ismaheel Lawal et al. JOURNAL OF NUCLEAR MEDICINE
- Tuberculosis
- (2018) Alfred O. Ankrah et al. SEMINARS IN NUCLEAR MEDICINE
- Monitoring Response to Therapy
- (2018) Mike M. Sathekge et al. SEMINARS IN NUCLEAR MEDICINE
- 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma
- (2018) Ismaheel O. Lawal et al. NUCLEAR MEDICINE COMMUNICATIONS
- Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response
- (2017) Adriano Queiroz et al. Revista da Sociedade Brasileira de Medicina Tropical
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
- (2016) Stephanus T Malherbe et al. NATURE MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- 18F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response
- (2012) V. Martinez et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Image Characteristics as Predictors for Thoracoscopic Anatomic Lung Resection in Patients With Pulmonary Tuberculosis
- (2011) Yi-Ting Yen et al. ANNALS OF THORACIC SURGERY
- Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis
- (2011) M. Sathekge et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search